Table V.
Multivariate Cox regression analysis of PFS and OS of patients with serous EOC.
| Clinical parameter | PFS
|
OS
|
||||
|---|---|---|---|---|---|---|
| RR | 95% CI | p-value | RR | 95% CI | p-value | |
| Residual disease (≤2 vs. >2 cm) | 1.53 | 0.89–2.64 | 0.1200 | 3.06 | 1.32–7.12 | 0.0093 |
| Cyclin D1 (≤20 vs. >20%) | 2.70 | 1.35–5.41 | 0.0052 | 3.61 | 1.61–8.12 | 0.0019 |
| p27Kip1 (≤40 vs. >40%) | 1.01 | 0.59–1.72 | 0.9700 | 2.15 | 1.03–4.51 | 0.0420 |
Significant p-values are indicated in boldface type. EOC, epithelial ovarian cancer; PFS, progression-free survival; OS, overall survival; RR, relative risk; CI, confidence interval.